Mini reviewPublished 28 Feb 2023
Drug Related Issues in Geriatric Psychiatry
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Due to multi morbidity, frequent exposure to poly pharmacy, impairment of organ functions (especially liver and kidney) and age-related changes in the pharmacokinetics and pharmacodynamics of several drugs (such as increased benzodiazepine sensitivity), the European Medicines Agency and the International Conference on Harmonization consider the elderly to be a special population. A large German registry study showed that people with severe mental illness are suffering more frequently from somatic comorbidities and display a higher mortality rate than people without severe mental illness, leading to a reduction in life expectancy of up to 12.3 years. Elderly psychiatric patients must therefore be regarded as a particularly vulnerable population that deserves special care and attention. The purpose of the present study was to determine the frequency and characteristics of clinically relevant MRPs in a population of elderly psychiatric To this end, we conducted a retrospective cohort study on patients aged 60 and older who were treated on the gerontopsychiatric ward of the Hannover Medical School's Department of Psychiatry, Social Psychiatry and Psychotherapy.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Research and Technology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Andrew Wood”